Our priorities for philanthropic support include:
Stopping young lives being lost to brain tumours
Historically, brain tumour research has received just one per cent of all cancer research funding in the UK. As a result, survival rates have barely changed for decades and progress is urgently required. At present, the only treatment options for brain tumours are chemotherapy or invasive surgery. Developing new treatments can take as long as 20 years, but if the pandemic has shown us anything, it’s that research can deliver progress fast. It just needs funding, and for people to work together towards a common goal.
Professor Oliver Hanemann, Chair in Clinical Neurobiology
Helping people with Parkinson’s live full lives
Being in the South West, where there’s a stable patient population and a small number of secondary care providers, you can a build good relationship with the patient base and make sure that the work is having an impact where it’s needed the most
Dr Camille Carroll, Associate Professor in Neurology
Helping understand the impact of MS on patients
Our research group gets involved in a range of projects, from initiatives to improve clinical services to those designed to increase adoption of existing treatments and clinical research trialling new treatments – all ultimately seeking to improve outcomes for people living with MS
Professor Jeremy Hobart, Professor of Clinical Neurology
Seeking new treatments for Huntington's
There is real potential for the development of an effective therapy for this devastating neurological disease, for which there is currently no cure.
Professor Shouqing Luo, Professor of Neurobiology